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Mice transgenic for thymic stromal lymphopoietin (TSLP),
under regulation of the lymphocyte-specific promoter Lck,
develop cryoglobulinemia and membranoproliferative
glomerulonephritis (MPGN) similar to the disease in patients.
To determine whether infiltrating macrophages, a hallmark
of this disease, are deleterious or beneficial in the injury
process, we developed Lck-TSLP transgenic mice expressing
the human diphtheria toxin receptor (DTR) under control
of the monocyte/macrophage-restricted CD11b promoter
(Lck-TSLP;CD11b-DTR). Treatment with DT resulted in a
marked reduction of monocytes/macrophages in the
peritoneal cavity of both CD11b-DTR and Lck-TSLP;CD11b-DTR
mice and marked reduction of macrophage infiltration in
glomeruli of Lck-TSLP;CD11b-DTR mice. Lck-TSLP;CD11b-DTR
mice, with or without toxin treatment, had similar levels of
cryoglobulinemia and glomerular immunoglobulin
deposition as Lck-TSLP mice. Lck-TSLP;CD11b-DTR mice,
treated with toxin, had reduced mesangial matrix expansion,
glomerular collagen IV accumulation, expression of the
activation marker a-smooth muscle actin and transforming
growth factor-b1 in mesangial cells, and proteinuria
compared with control mice. Thus, macrophage ablation
confers protection in this model and indicates a
predominately deleterious role for macrophages in the
progression of kidney injury in cryoglobulinemic MPGN.
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Macrophages are key participants in inflammation, phago-
cytosis, tissue repair, and remodeling.1–4 They are commonly
present in glomerulonephritis (GN), and a large influx of
monocytes/macrophages is a particular feature of human
cryoglobulinemic membranoproliferative GN (MPGN).
Although a characteristic feature of this injury, it is still
unknown whether the infiltrating monocytes/macrophages
fulfill a predominantly beneficial/reparative role in the
evolution of this disease or whether they are predominately
effectors or promoters of glomerular injury and sclerosis.
We have characterized a mouse model of cryoglobu-
linemia with consequent development of MPGN, the
thymic stromal lymphopoietin (TSLP) transgenic mouse
(Lck-TSLP), which overexpresses TSLP and has resultant
abnormalities in B-cell development.5–7 Lck-TSLP mice
develop mixed cryoglobulinemia and a systemic inflamma-
tory disease that involves kidney, lung, spleen, liver, and
skin.5–7 These mice develop a renal disease that closely
resembles human cryoglobulinemia-associated MPGN. The
glomerular injury is characterized by extensive subendo-
thelial capillary and mesangial immune deposits, marked
monocyte/macrophage influx, mesangial cell proliferation
and matrix expansion, and capillary wall splitting. The renal
lesion is evident from about age 30 days in female mice and
rapidly progresses to fully developed MPGN by age 50 days.
There are also significant lung,5–7 liver,5–7 and skin lesions.8,9
Female mice usually die at 60 days to 70 days, presumably
from severe lung disease. Male mice have a similar but more
slowly evolving course, in which the disease is fully manifest
by 120 days.5–7
A number of approaches to delete monocyte/macrophage
populations, including the use of anti-macrophage serum
and liposome-encapsulated clodronate, has been used to test
the importance of monocytes/macrophages in vivo in renal
disease processes.10–12 Monocyte/macrophage depletion using
liposomal clodronate reduced tubulointerstitial inflamma-
tion and fibrosis in ischemia/reperfusion injury in the rat and
mouse.13,14 A unique CD11b-DTR transgenic mouse, in
which human diphtheria toxin receptor (DTR) is specifically
expressed by CD11b-expressing cells, allows conditional
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ablation of mouse monocytes/macrophages by administra-
tion of DT. These mice have been carefully characterized for
specificity of ablation, and used to study peritoneal
inflammation, kidney fibrosis, kidney repair and regenera-
tion, lung, liver and pancreas injury, wound healing, and
atherosclerosis.15–18 In a model of rapidly progressive
glomerular injury, injection of DT for 5 days, beginning at
days 15–20 after a single administration of nephrotoxic serum
in CD11b-DTR mice, resulted in markedly reduced glomer-
ular crescents, attenuated tubular injury, and improved
renal function.18 The effect of monocyte/macrophage deple-
tion has not been tested in a model of chronic GN with active
and persistent immune complex deposition, such as that
occurs in the cryoglobulinemic Lck-TSLP mice and in
many patients with MPGN. In this study, we demonstrate
that macrophages are essential contributors to the progres-
sion of GN and that their presence is a deleterious mani-
festation of injury.
RESULTS
Lck-TSLP; CD11b-DTR and Lck-TSLP mice develop equivalent
spontaneous glomerulonephritis
Lck-TSLP mice and CD11b-DTR mice, both on C57BL/6
background, were bred to obtain double-transgenic mice
(Lck-TSLP; CD11b-DTR). Cohorts of C57BL6 wild-type
(WT), CD11b-DTR, Lck-TSLP, and Lck-TSLP; CD11b-DTR
mice were studied with intraperitoneal administration of
20 ng/g DT body weight or similar volume of phosphate-
buffered saline (PBS) from age days 30–50.
CD11b-DTR mice are similar to WT mice with no
detectable kidney pathology. The Lck-TSLP; CD11b-DTR
mice have similar levels of serum cryoglobulinemia,
measured by cryocrits, as to Lck-TSLP mice (data not
shown). Both Lck-TSLP and Lck-TSLP; CD11b-DTR mice
developed typical features of cryoglobulin-associated MPGN
as described previously.5 Mice showed progressive kidney
injury from age 30 days (Lck-TSLP; CD11b-DTR-30D) to
age 50 days, with extensive mesangial cell proliferation
and mesangial matrix expansion as demonstrated by
increased glomerular tuft area, glomerular hypercellularity,
and increased silver methanemine-stained extracellular
matrix (Figures 1 and 2). Mesangial cell activation, assessed
by a-smooth muscle actin (a-SMA) expression, was also
markedly increased.
Glomerular macrophages in Lck-TSLP mice show marked
heterogeneity
Day 50 Lck-TSLP mice show a fivefold increase in glomerular
Mfs compared with WT mice: 2.32±0.2 CD68þ cells per
glomerular tuft area versus 0.64±0.05 cells in WT mice.
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Figure 1 |Macrophage ablation results in amelioration of glomerulonephritis. Histological appearance of glomeruli stained with
hematoxylin and eosin (H&E) (a–e), silver methenamine (f–j), and immunohistochemical (IHC) staining for type IV collagen (k–o), and
a-smooth muscle actin (a-SMA) (p–t) in wild-type (WT) and CD11b-DTR mice of 50 days of age after 20 days diphtheria toxin (DT) treatment
(WT-DT and CD11b-DTR-DT, respectively), Lck-TSLP; CD11b-DTR mice at 30 days of age (Lck-TSLP; CD11b-DTR-30D), and Lck-TSLP; CD11b-DTR
mice at 50 days of age after 20 days of phosphate-buffered saline (PBS) or DT intraperitoneal administration (Lck-TSLP; CD11b-DTR-PBS and
Lck-TSLP; CD11b-DTR-DT, respectively). Lck-TSLP; CD11b-DTR mice with PBS treatment show increased glomerular cellularity, mesangial
matrix accumulation (black silver staining area increase and type IV collagen expression increase), and mesangial a-SMA expression as
compared with WT and CD11b-DTR mice, whereas Lck-TSLP; CD11b-DTR mice with DT treatment demonstrate less hypercellularity,
significantly reduced mesangial matrix expansion, and reduced a-SMA expression in glomeruli. Original magnification:  400.
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In order to gain further insight into the function of these
inflammatory macrophages, we characterized them by
immunofluorescent staining for recognized markers of
M1-type, M2-type, and reparative Mfs (Figure 3, Table 1).
Strikingly, the CD68þ cells showed high levels of CD11a
expression, Ly6C expression, and a proportion expressed
CD40, all markers associated with the M1 activated injurious
phenotype. Surprisingly, the vast majority of glomerular Mfs
also expressed some markers associated with M2 or wound
healing, namely the scavenger receptor CD206 and galectin-3
(M2). However, other M2-type markers such as integrin b5
and transferrin receptor were expressed in a minority.
Glycoprotein non-metastatic melanoma B-expressing macro-
phages have been strongly associated with tissue repair in
kidney and liver,19 and a minority of the glomerular Mfs also
expressed this marker.
Administration of DT reduced blood monocytes and
markedly reduced peritoneal and glomerular macrophage
infiltration
Flow cytometry analysis of blood monocytes and peritoneal
macrophages in Lck-TSLP; CD11b-DTR mice showed that
blood monocytes expressing CD11b were reduced in the
blood in DT-treated (Lck-TSLP; CD11b-DTR-DT)
(2.1±0.6%) mice compared with PBS-treated (Lck-TSLP;
CD11b-DTR-PBS) (4.3±0.7%) mice (Table 2). Resident
peritoneal macrophages were reduced to 4.5±1.5% of total
peritoneal cells in DT-treated mice compared with
22.7±2.6% in PBS-treated Lck-TSLP; CD11b-DTR mice
(Table 2). Circulating CD3-expressing T cells were not
changed with DT treatment (Table 2).
Both Lck-TSLP and Lck-TSLP; CD11b-DTR mice have
remarkable influx of macrophages in glomeruli as measured
by immunohistochemistry detection of Mac-2 (galectin-3)
and CD68 epitopes (Figure 3). There are few Mac-2- or
CD68-expressing cells in the tubulointerstitium in Lck-TSLP
and Lck-TSLP; CD11b-DTR mice, and these mice do not
develop significant tubular atrophy, tubulointerstitial inflam-
mation, or fibrosis.
Lck-TSLP mice treated with either DTor PBS have similar
macrophage infiltration in glomeruli. Administration of DT
in Lck-TSLP; CD11b-DTR mice resulted in a significant
reduction in infiltration of macrophages in glomeruli
(Figure 4). A significant reduction in glomerular monocyte/
macrophage infiltration was also observed when using
another marker of macrophages, CD68 (Figure 4g and h).
There was an increase in F4/80-positive cells (a marker
expressed by monocyte/macrophages preferentially localized
to the tubulointerstitium versus glomeruli) infiltrating the
tubulointerstitium in Lck-TSLP; CD11b-DTR mice compared
with WT and CD11b-DTR mice (Figure 4i–l). Morphometric
analysis demonstrated a trend toward reduction in F4/80-
positive interstitial macrophages with DT administration in
Lck-TSLP; CD11b-DTR (0.33±0.13% versus 0.17±0.09%
positive staining per interstitial area), but results were not
statistically significant between any of the groups. There was
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Figure 2 |Macrophage ablation with diphtheria toxin halts
progression of disease as shown by morphometric analysis.
(a) Glomerular silver staining matrix; (b) glomerular type IV
collagen accumulation; and (c) glomerular a-smooth muscle actin
(a-SMA) expression is depicted in wild type (WT), CD11b-DTR mice
with DT treatment at 50 days of age, Lck-TSLP; CD11b-DTR mice
at 30 days of age, and Lck-TSLP; CD11b-DTR mice at age 50 days,
after 20 days of DT or PBS intraperitoneal administration. Lck-TSLP;
CD11b-DTR mice treated with diphtheria toxin (DT) have
significantly reduced expansion of silver-stained extracellular
matrix and glomerular type IV collagen expression compared
with the phosphate-buffered saline (PBS) control group.
A marker of mesangial cell activation, a-SMA is reduced in
Lck-TSLP; CD11b-DTR mice treated with DT compared to those
receiving PBS treatment (n¼ 5–6 in each group). *Po0.001,
#Po0.01, þPo0.05 versus Lck-TSLP; CD11b-DTR-PBS group. GTA,
glomerular tuft area.
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modest T-cell (CD3þ ) infiltration in the interstitium, but
few T cells in glomeruli in any group. There was no
significant difference in glomerular neutrophils assessed by
Ly6G expression between the groups (neutrophils/glomerular
cross-section: CD11b-DTR-DT: 0.059±0.017; Lck-TSLP;
CD11b-DTR-PBS: 0.060±0.009; Lck-TSLP; CD11b-DTR-
DT: 0.046±0.008, not significant).
Monocyte/macrophage ablation improves kidney pathology
in Lck-TSLP; CD11b-DTR mice
C57BL6 WT and CD11b-DTR mice treated with DT for 20
days after age 30 days did not show kidney alterations, and
were comparable with PBS-treated control mice. Lck-TSLP
mice treated with DT for 20 days after age 30 days developed
a progressive GN indistinguishable from that of Lck-TSLP
mice treated with PBS.
Lck-TSLP; CD11b-DTR mice treated with DT have
significantly reduced extracellular matrix expansion
compared with Lck-TSLP; CD11b-DTR mice treated with
PBS, as measured by silver-stained extracellular matrix
(Figures 1 and 2). Type IV collagen, a major component
of extracellular matrix, was also significantly reduced in the
DT-treated Lck-TSLP; CD11b-DTR group; a-SMA, expressed
only by activated mesangial cells, was significantly attenuated
CD68 CD11b
CD68 Ly6C
CD68 TFRC CD68 ITGB5 CD68 CD206
CD68 GPNMB CD68 Mac2
CD68 CD11a CD68 CD40
Figure 3 |Representative double immunofluorescence images of glomeruli from Lck-TSLP mice showing glomerular CD68-positive
macrophages and expression of characteristic M1 markers CD11a and Ly6C, characteristic M2 markers Mac2 and CD206, as well as
other markers expressed by macrophage subsets. Double-stained macrophages are indicated with arrowheads. Bar¼ 20mm.
Table 1 | Proportion of CD68+ macrophages (M/s) in glomerular tuft of Lck-TSLP mice that co-express other markers
CD68 CD11b CD11a CD40 Ly6C GPNMB Mac-2 TFRC ITGB5 CD206
% CD68+ Mfs 100.0 91.7 100.0 25.0 75.0 25.0 100.0 0.0 50.0 83.3
Standard error 50.0 20.0 8.3 25.0 16.7 15.0 0.0 25.0 16.7
Abbreviations: GPNMB, glycoprotein nonmetastatic melanoma B; ITGB5, integrin B5; TFRC, transferrin receptor; TSLP, thymic stromal lymphopoietin.
Examples of co-expression are shown in Figure 3.
Data are shown as average±s.e.
N=3 mice (10–15 glomeruli/mouse).
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by monocyte/macrophage deletion, indicating that glomer-
ular monocyte/macrophages must activate mesangial cells
(Figures 1 and 2).
Proteinuria was markedly reduced by DT treatment
in Lck-TSLP; CD11b-DTR mice
Urine albumin excretion increased by fivefold in untreated
Lck-TSLP and Lck-TSLP; CD11b-DTR mice at age 30 and
50 days. Macrophage ablation treatment markedly reduced
albumin excretion in Lck-TSLP; CD11b-DTR mice (urine
albumin/creatinine ratio (mg/mg); Figure 5a). Although the
mice have a florid GN, renal function is preserved, as
detected by serum blood urea nitrogen. Monocyte/macro-
phage ablation had no impact on renal function (Figure 5b).
DT treatment in Lck-TSLP; CD11b-DTR mice decreased renal
TGF-b1 expression
Both Lck-TSLP and Lck-TSLP; CD11b-DTRmice express high
transforming growth factor (TGF)-b1 transcript levels in
the kidney. Monocyte/macrophage ablation decreased
the TGF-b1 transcripts in Lck-TSLP; CD11b-DTR mouse
kidneys (Figure 6a). Detection of TGF-b1 protein in
kidney homogenates by enzyme-linked immunosorbent assay
revealed a similar pattern to that of TGF-b1 transcripts:
Lck-TSLP; CD11b-DTR mice with monocyte/macrophage
ablation have reduced TGF-b1 protein levels compared with
Lck-TSLP; CD11b-DTR mice with the normal complement of
macrophages (Figure 6b).
TGF-b1 expression was restricted to the glomerular
mesangium in Lck-TSLP; CD11b-DTR mice (Figure 7a) and
monocyte/macrophage ablation decreased protein expression
in this region (Figure 7b). Interstitial TGF-b1 was not
detected in Lck-TSLP; CD11b-DTR mice.
Monocyte/macrophage ablation did not influence renal
immunoglobulin or complement deposition
Immunofluorescence analysis showed that Lck-TSLP mice
had intense deposition of IgG, IgM, and to a lesser extent of
IgA and complement C3 in glomeruli. Monocyte/macro-
phage ablation did not change the extent or intensity of
staining of deposited immunoglobulins and complement C3
(Figure 8).
Monocyte/macrophage ablation attenuates liver, but not
lung lesions, in Lck-TSLP; CD11b-DTR mice
All Lck-TSLP and Lck-TSLP; CD11b-DTR mice had circulat-
ing cryoglobulins, whereas WT and CD11b-DTR mice did
not. The administration of DT did not change the cryocrit
levels (a measurement of plasma cryoglobulin content) in
Lck-TSLP or Lck-TSLP; CD11b-DTR mice (data not shown),
indicating that ablation did not impact immunoglobulin
production or splenic clearance. This is not surprising
because splenic macrophages are not ablated in CD11b-
DTR mice.15,16
The cryoglobulinemia in Lck-TSLP or Lck-TSLP; CD11b-
DTR mice causes systemic disease, which involves the liver
and lung.7,8 Both Lck-TSLP and Lck-TSLP; CD11b-DTR mice
have increased liver and lung weights. Histological evaluation
of the liver showed periportal leukocyte infiltration in both
Lck-TSLP and Lck-TSLP; CD11b-DTR mice.5,9 The lung
lesion in Lck-TSLP and Lck-TSLP; CD11b-DTR mice is
characterized by marked perivascular and peribronchiolar
leukocyte infiltration. As assessed by Mac-2 expression, in the
liver, the periportal infiltrating cells are mainly macrophages,
whereas only a minority of perivascular and peribronchiolar
leukocytes in the lung are macrophages (Figure 9). The
hepatic periportal leukocyte infiltration was significantly
reduced by administration of DT Lck-TSLP; CD11b-DTR
mice (Figure 9 and Table 3). However, DT treatment had no
impact on lung macrophage infiltration. Kupffer cells of
normal liver and lung alveolar macrophages are also Mac-2-
positive, but DT treatment did not affect these myeloid cells
(Figure 9).
DISCUSSION
Monocyte/macrophages are a heterogeneous population of
cells, and their effects on different diseases or even on
different stages of diseases are often difficult to assess. One
unresolved issue in human GN is whether the prominent
monocyte/macrophage influx that characterizes cryoglob-
ulinemic MPGN is primarily deleterious and is an effector of
disease, or primarily beneficial and involved in disease
stabilization and repair.
Our study showed that from the time MPGN is first
detected (day 30), but when the disease is not advanced,
monocyte/macrophages had mainly a detrimental role in
disease progression. The specific mechanism by which
monocytes/macrophages exert their deleterious effects
remains unknown. The elimination of the monocyte-derived
cell population had no effect on serum levels of cryoglob-
ulinemia or on the extent of glomerular immune complex
deposition. This indicates that the effect of ablation of
glomerular macrophage infiltration on the kidney was due to
events related to amplification of injury following immune
Table 2 | Ablation of peritoneal macrophages (F4/80-positive)
and blood monocytes (CD11b-positive) after administration
of DT or PBS to Lck-TSLP; CD11b-DTR micea,b
Peritoneal cavity (% of total cells) CD3 F4/80
DT 3.4±1.2 4.5±1.0c
PBS 4.5±1.5 22.7±2.6
Blood (% of leukocytes) CD3 CD11b
DT 3.5±0.8 2.1±0.6d
PBS 3.8±0.6 4.3±0.7
Abbreviations: DT, diphtheria toxin; DTR, DT receptor; PBS, phosphate-buffered
saline; TSLP, thymic stromal lymphopoietin.
aPeritoneal lavage and blood are collected 24 h after intraperitoneally injected with
20 ng/g DT body weight or PBS when the age of mouse is day 30.
bData are shown as mean±s.e.m. (n=4 in each group).
cPo0.05 versus wild-type mice.
dPo0.001 DT-treated versus PBS-treated Lck-TSLP;CD11b-DTR mice.
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Figure 4 |Treatment of Lck-TSLP;CD11b-DTR mice with diphtheria toxin results in diminished numbers of glomerular macrophages,
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complex deposition, and was unlikely because of a result
of immune complex clearance functions performed by
these cells.
We had speculated that the amplification of injury
following glomerular immune complex deposition may occur
by activation of infiltrating monocyte/macrophages via their
Fc receptors.20–23 In previous studies of this model, we
have shown that genetic deletion of the inhibitory FcgIIb
receptor can substantially worsen disease manifestations,
which may be due to loss of inhibition of B-cell functions.24
Genetic deletion of the FcR g-chain common to the
activating receptors FcgIR, FcgIIIR, and FcgIVR (which
results in lack of cell surface expression of these receptors)
does not result in an opposite effect of amelioration of
MPGN, suggesting that a key role of these activating
receptors on leukocytes is to facilitate the clearance of the
deposited immune complexes, rather than activation of
monocyte.25 This presents a potential paradox for under-
standing how the loss of infiltrating monocytes/macrophages,
the principal infiltrating leukocyte in cryoglobulinemic
MPGN, and the cells most strongly implicated in phagocytic
removal of deposited immune complexes, can still result in
diminished manifestations of disease.
We have considered activities of monocytes/macrophages,
other than those involved in the clearance of immune
complexes, to address this paradox. For example, activation
of monocyte/macrophage via Fc receptor engagement can
induce production of interleukin-10, which is not only an
anti-inflammatory factor but which also promotes produc-
tion of growth factors for wound healing, such as TGF-b1,
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Figure 5 |Macrophage ablation reduces proteinuria in membranoproliferative glomerulonephritis. (a) Proteinuria measured as urine
albumin/creatinine ratio (ACR) (expressed as mg/mg). Lck-TSLP; CD11b-DTR mice have markedly increased urine albumin excretion compared
with wild-type (WT) and CD11b-DTR mice. Lck-TSLP; CD11b-DTR mice with diphtheria toxin (DT) treatment demonstrate significantly
decreased proteinuria compared with Lck-TSLP; CD11b-DTR mice with phosphate-buffered saline (PBS) treatment (n¼ 4–5 each group).
*Po0.001, #Po0.01 versus Lck-TSLP; CD11b-DTR-PBS group. (b) Serum blood urea nitrogen (BUN) measurements (mg/dl). There is no
difference between each group (n¼ 4–5 each group).
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which, in some tissues, may result in resolution of
inflammation and healing.26–28 However, the continuous
production of growth factors for wound healing such as
TGF-b1 can be deleterious and result in progressive fibrosis
or sclerosis,20 and in the glomerulus it has been amply
demonstrated that TGF-b1 promotes the production of
glomerular matrix by mesangial cells.26 Our study showed
that deletion of monocytes/macrophages resulted in reduced
mesangial production of TGF-b1, both at the mRNA
and protein levels. Furthermore, we demonstrated that there
was concurrently reduced expression of the mesangial cell
activation marker a-SMA,29,30 and that these events corre-
lated with markedly reduced mesangial production of type IV
collagen and presumably other unmeasured components of
the expanded mesangial matrix. This suggests a scenario
whereby infiltrating monocyte/macrophages, communicating
with mesangial cells, initiate a cascade of events that begins
with mesangial cell activation, leading to upregulated
mesangial production of TGF-b1, which then acts upon
these cells in an autocrine manner to drive the progressive
glomerular matrix accumulation that occurs in MPGN. This
scenario is then disrupted when glomerular macrophage
infiltration is ablated.
An extended alternative explanation for our observations
is that molecules released from injured cells of the glomerulus
(endothelial, mesangial, and podocytes) serve as activating
factors for recruited monocytes. These injury molecules
known as danger-associated molecular patterns (DAMPs)
may be responsible for the unscheduled activation of
macrophages, hindering their innate function to clear
immune complexes via FcgRs and complement receptors,
and leading to pro-inflammatory cytokine release, which
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Figure 6 | Transforming growth factor-b1 levels are altered by macrophage ablation. (a) Kidney transforming growth factor (TGF)-b1
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then drives mesangial expansion and activation as a wound
healing response.31–36 DAMPs can stimulate different types of
activation of macrophages. Classically activated macrophages
of M1 type (stimulated by bacterial cell wall molecules or
interferon-g) are widely believed to be injurious. Many
DAMPs, including mitochondrial proteins and Toll-like
receptor ligands, similarly activate macrophages.31–36 In
contrast, macrophages stimulated by other cytokines and
DAMPs including adenosine can adopt wound healing or
reparative phenotypes.37 We characterized the glomerular
macrophages in this MPGN model and many of them
expressed M1-type markers. However, they concurrently
expressed markers, including Mac-2 and CD206, associated
with wound-healing functions. Moreover, a minority of
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Figure 8 |Macrophage ablation did not change glomerular immunoglobulin or C3 deposition. Representative photographs of
glomerular immunofluorescence in Lck-TSLP; CD11b-DTR mice treated with phosphate-buffered saline (PBS) (a–d) and diphtheria toxin (DT)
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(d, h). DT treatment has no effect on glomerular immune complex deposition/accumulation. Original magnification:  400.
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glomerular macrophages expressed glycoprotein non-meta-
static melanoma B, an intracellular protein associated with
reparative functions.19 This phenotypic heterogeneity may
reflect transitions between one phenotype and another,
but alternatively it may reflect widely differing tasks of
macrophages in the glomerulus. We speculate that multiple
DAMPs induced by the initial injury of cryoglobulinemic
MPGN both recruit and activate these different types of
macrophages. Accordingly, as CD11b-DTR ablation does not
discriminate between activation states in the kidney,38 it is
likely that the result of ablation reflects the function of
most of the macrophages in the glomerular compartment.
As these studies indicate that a major function of glomerular
macrophages in MPGN is to activate myofibroblasts and
promote matrix accumulation (M2- or wound-healing-
type functions); therefore, it is not surprising that many
macrophages express the M2 markers Mac-2 and CD206
and that their ablation can result in improvement in
glomerular injury.
The improvement in structural glomerular injury after
macrophage depletion was accompanied by functional
improvement, indicated by a reduction of proteinuria. In
contrast, the blood urea level was not changed in the Lck-
TSLP and Lck-TSLP; CD11b-DTR mice with or without DT
treatment, compared with the WT and CD11b-DTR mice.
This may be due to the minimal tubulointerstitial injury in
these mice, or due to the relative insensitivity of changes in
blood urea nitrogen to glomerular disease in mice.
The effects of DT on monocyte/macrophage populations
in different tissues/organs are varied. It has been shown
a
e
i
m n o p
j k l
f g h
b c d
WT-DT
Liver
H&E
Lung
H&E
Liver
Mac-2
Lung
Mac-2
CD11b-DTR-DT Lck-TSLP;CD11b-
DTR-PBS
Lck-TSLP;CD11b-
DTR-DT
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photographs of liver (a–d) and lung (e–h) tissues stained with hematoxylin and eosin (H&E). Hepatic inflammation is significantly reduced
with diphtheria toxin (DT) treatment in Lck-TSLP; CD11b-DTR mice. Lung inflammation is similar in distribution and in extent in both
phosphate-buffered saline (PBS)- and DT-treated Lck-TSLP; CD11b-DTR mice. Representative photographs of liver (i–l) and lung (m–p) tissues,
stained with the monocyte/macrophage marker Mac-2. In WT and CD11b-DTR mice, perisinusoidal Kupffer cells are Mac-2-positive. Most of
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reduction of periportal macrophage infiltration in the liver. DT treatment had no effect on the Kupffer cells. In the lung, alveolar
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Table 3 | Semiquantitative grading of lung and liver
inflammationa
Lck-TSLP;
CD11b-DTR-30D
Lck-TSLP;
CD11b-DTR-PBS
Lck-TSLP;
CD11b-DTR-DT
Lung inflammation 2.0±0.4 2.6±0.3 2.5±0.4
Liver inflammation 2.2±0.5 2.4±0.4 1.5±0.6
Abbreviations: DT, diphtheria toxin; DTR, DT receptor; PBS, phosphate-buffered
saline; TSLP, thymic stromal lymphopoietin.
aData are shown as mean±s.e.m. (n=6 in each group).
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previously that injection of DT in CD11b-DTR mice can
result in reduction of resident macrophages in ovaries and
kidneys, but the resident lung alveolar macrophage and liver
sinusoidal macrophage (Kupffer cells) are not altered.15 In
the present study, both the alveolar resident macrophages and
the monocyte/macrophages infiltrating lung were not
sensitive to DT administration, and this intervention did
not change the overall degree of lung inflammation. In the
liver, the liver sinusoidal Kupffer cells were resistant to DT,
but the periportal infiltration of macrophages was signifi-
cantly reduced by DT administration.
In summary, we show that targeting of monocytes/
macrophages, characteristically present in both human and
murine cryoglobulinemic MPGN, may be an efficacious
therapeutic approach for this disorder, and can result in
decreased production of TGF-b1, an established mediator of
progressive glomerular injury. The influence of monocytes/
macrophages on mesangial cell activation is comple-
mentary to the effects of glomerular cryoglobulin deposition,
previously shown by us to be important in inducing
production of serine proteases by mesangial cells.39 Cryo-
globulin deposition is essential for the recruitment of
monocytes/macrophages in this disorder, and therefore these
processes are likely synergistic in activating the mesangium at
the outset of glomerular disease; however, the influence of
monocytes/macrophages on mesangial cells subsequent to
their recruitment is the more dominant process affecting
progressive glomerular injury in the Lck-TSLP MPGN model.
The effect on mesangial activation delineates a key activity
of monocytes/macrophages in MPGN in addition to their
role in disposition of deposited immune complexes, and
indicates multiple roles for monocyte/macrophages in
mediating this disease.15
MATERIALS AND METHODS
Animals and intervention
The experimental protocol of this study was reviewed and approved
by the Animal Care Committee of the University of Washington.
Mice were housed under standard conditions and received normal
chow and water ad libitum in a specific pathogen-free facility. Lck-
TSLP transgenic mice and CD11b-DTR transgenic mice, both on
C57BL6 background, were crossed to develop double-transgenic
mice (Lck-TSLP; CD11b-DTR). Cohorts of female C57BL6 WT,
CD11b-DTR, Lck-TSLP, and Lck-TSLP; CD11b-DTR mice (n¼ 5–6
in each group), were studied.
Diphtheria toxin (1.0mg) (List Biological Laboratories, Campbell,
CA) was reconstituted with 1.0ml sterile distilled water and then
diluted to 2 ng/ml in sterile PBS. Mice at age 30 days, when kidney
disease is early in its evolution in female Lck-TSLP mice as
previously documented, were injected intraperitoneally with 20 ng/g
DT body weight or similar volume of vehicle (PBS), every other
alternate day for 20 days.
Tissue collection and histological staining
The genotyped groups of mice (n¼ 5–6 in each group) were
analyzed at 30 days and 50 days after birth following 20 days of DT
or PBS treatment. Blood was collected under an anesthetic before
collecting kidney, liver, and lung. Portions of each organ were fixed
in 10% neutral-buffered formalin or methyl Carnoy’s solution.
These tissues were processed, embedded in paraffin, and histological
sections were prepared using standard procedures. Tissue sections
were stained with hematoxylin and eosin, periodic acid-Schiff, and
silver methenamine reagents (silver staining). Portions of cortical
kidney were snap-frozen and stored in 80 1C for subsequent
isolation of RNA and protein. Portions of kidney in Tissue-Tek
OCT compound (Sakura Finetek USA, Torrance, CA) were
snap-frozen and stored at 80 1C, and sectioned at 5 mm, fixed in
cold acetone or methanol for 10min, and then used for immuno-
fluorescence analysis. Both frozen and paraffin-embedded tissues
were used in immunohistochemistry studies. In some experiments,
organs were fixed in PLP solution before cryosectioning as
previously described.40,41
Immunostaining and immunofluorescence
The general immunohistochemistry protocols used have been
described previously.5,24,40,41 Type IV collagen was detected in
paraffin-embedded tissue by a goat polyclonal anti-human type IV
collagen antibody that cross-reacts with mouse type IV collagen
(Southern Biotechnology, Birmingham, AL).7,8 Glomerular mesan-
gial cell activation was evaluated in paraffin-embedded tissue by
a-SMA expression.7,30 Tissues were first blocked by Rodent Block M
(Biocare Medical, Concord, CA) and then incubated with a mouse
monoclonal anti-human a-SMA antibody (Dako, Carpinteria, CA).
After washing, MM-HRP Polymer (Biocare Medical) was added
and then detected with DAB substrate. Monocytes/macrophages
were detected by a rat anti-mouse Mac-2 antibody (Cedarlane,
Ontario, Canada) in paraffin-embedded kidney, liver, and lung
tissues.7,8 Monocytes/macrophages in the kidney were also detected
by a rat anti-mouse CD68 antibody (AbD Serotec, Raleigh, NC)
using frozen kidney tissue and F4/80 (AbD Serotec) in paraffin
tissue sections. T cells and neutrophils were identified using rat anti-
mouse CD3 antibody (AbD Serotec) and rat-anti-Ly6G antibody
(eBioscience, San Diego, CA), respectively, in paraffin-embedded tissue.
Kidney TGF-b1 expression was evaluated by staining with a rabbit anti-
mouse TGF-b1 polyclonal antibody (Santa Cruz Biotechnology, Santa
Cruz, CA) on frozen kidney tissue.7,8,42 To detect immunoglobulins,
acetone-fixed cryosections were air-dried and washed in PBS, then
incubated with fluorescein-conjugated antibodies against mouse IgG,
IgM, IgA, and complement C3 (Cappel Pharmaceuticals, Aurora, OH)
as previously described,7,8 and then mounted in Vectashield (Vector,
Burlingame, CA). In a blinded manner, the glomerular fluorescence
intensity was described semiquantitatively (0, negative; 1, weak; 2,
moderate; 3, strong). For every sample, 15 glomeruli were evaluated
and the mean score was calculated.
In PLP-fixed cryosections, macrophages and macrophage sub-
populations were detected using methods previously reported40,41
by antibodies against the following epitopes: CD68 and CD68-FITC
(1:200 Abd Serotec), CD11b, CD11b-FITC (1:400 eBioscience),
CD11a, Ly6C, CD206-FITC, CD40 (1:200 BD Pharmingen, San
Diego, CA), Mac-2-FITC (1:200 Cedarlane), transferrin receptor,
integrin b5 (1:200 Invitrogen, Carlsbad, CA), and glycoprotein non-
metastatic melanoma B (1:1000).19 Where appropriate, affinity-
purified anti-rat-Cy3 or anti-rabbit-Cy3 antibodies (1:800 Jackson
Immunoresearch, West Grove, PA) were applied. After washing and
post fixation (1% paraformaldehyde), sections were mounted with
Vectashield containing 4’,6-diamidino-2-phenylindole. For double
staining, unlabeled primary antibody followed by Cy3-conjugated
secondary antibody was followed by a second FITC-conjugated
antibody recognizing CD68 or CD11b.
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Analysis of renal function
Before collection of mouse organs, spot urine was collected. Urine
albumin level was measured by enzyme-linked immunosorbent
assay, (Albuwell, Exocell, Philadelphia, PA) and urine creatinine level
was measured using the Creatinine Companion kit (Exocell)
according to protocols of the manufacturer. Proteinuria level was
evaluated by urine albumin/creatinine ratio. Serum blood urea
nitrogen level was measured with the liquid urea nitrogen reagent set
(Pointe Scientific, Canton, MI).
Measurements of serum cryoglobulins
Blood was allowed to clot at 37 1C and serum was collected by
centrifugation (3000 r.p.m., 10min). Serum was stored at 4 1C for a
minimum of 72 h and the formation of cryoprecipitate was
identified and serum cryoglobulin concentration (cryocrit) was
measured as previously described.5,7
Quantitative real-time PCR and enzyme-linked
immunosorbent assay measurements of TGF-b1 in
kidney tissue
Portions of frozen cortical kidney tissue were weighed, homo-
genized, and total kidney RNA and protein was extracted using the
PARIS kit (protein and RNA isolation system) (Ambion, Austin,
TX). The isolated mRNA was converted to cDNA using Retroscript
RT-PCR kit (Ambion). Real-time PCR was performed using
Taqman gene expression assay kits for the primers and probes of
mouse TGF-b1 gene and glyceraldehyde-3-phosphate dehydrogenase
gene (Applied Biosystems, Foster City, CA). The fold change of the
expression level of TGF-b1 transcript in Lck-TSLP mice compared
with WT mice was normalized to the endogenous housekeeping
gene glyceraldehyde-3-phosphate dehydrogenase. The isolated protein
homogenates were used for TGF-b1 protein measurement using
TGF-b1 enzyme-linked immunosorbent assay (eBioscience). Total
TGF-b1 protein was normalized to the weight of the kidney tissue
from which the protein was extracted.
Peritoneal macrophages and blood monocyte ablation test
Twenty-four hours after intraperitoneal injection with 20 ng/g DT
body weight or similar volume of vehicle (PBS), when the mouse
was 30 days of age, peritoneal cells were collected by peritoneal
lavage with 3ml of PBS. Blood was collected retro-orbitally and was
treated with red blood cell lysis buffer (Invitrogen). Cells were
blocked in FcR Block (BD Pharmingen). Anti-mouse CD11b-FITC
and anti-F4/80-FITC (AbD Serotec) were used as markers for
monocytes in blood and macrophages in peritoneal cavity,
respectively, and anti-mouse CD3-PE (BD Pharmingen) was used
as marker for T cells, were added in 50 ml total volume and
incubated at 4 1C for 30min. Cells were washed in FACS buffer three
times followed by flow cytometry.
Glomerular and interstitial morphometry
Fifteen random glomerular cross-sections were photographed
using an Olympus DP11 digital camera (Olympus, Melville, NY).
Five non-overlapping, low-power cortical fields were photographed
to quantify interstitial macrophages. Photography and subsequent
morphological analyses were performed by an examiner blinded to
the origin of the samples. The photographs were imported and
analyzed using the ImagePro Plus software (Media Cybernetics,
Silver Spring, MD). Glomerular tuft area and the proportion of the
glomerular area occupied by black silver methenamine-stained
matrix or stained by antibodies to type IV collagen, TGF-b1, or the
proportion occupied by cells expressing a-SMA, or Mac-2 were
quantified as previously described.6–8,24 Similarly, cortical area
and the area occupied by cells expressing F4/80 were quantified.
Ly6G-positive neutrophils were counted in a minimum of 75
glomerular cross-sections.
Analysis of extrarenal involvement
Liver and lung tissue sections stained with hematoxylin and eosin
were assessed for evidence of systemic injury. As previously described,
the liver and lung inflammation was scored semiquantitatively on a
scale of 0–3: 0, no inflammation; 1, mild; 2, moderate; 3, severe with
regard to the extent and density of leukocytic infiltration.7,8
Statistical analysis
All data are expressed as mean±s.e.m. Statistical analysis of the data
for multiple groups was performed using analysis of variance with
Tukey–Kramer multiple comparisons test using the InStat program
(Version 3.0, Intuitive Software for science, San Diego, CA). Po0.05
was considered significant.
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